Manufactures non-woven materials used in various applications, including hygiene and healthcare. Now — the numbers.
Revenue is spread across several lines; no single product carries the company.
This is an established company with proven profits.
No real growth (1% a year).
The gap is $7.8B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 15.2× for every dollar of annual profit — around what a business like this usually costs.
Analysts' average target sits 8% above today's price.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It pays out $1.17 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales grew only 1% a year on average. At this size, speeding back up is not easy.
The price action doesn’t yet back an upward turn. Council score: 0/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.